Jonathan Aschoff's Stock Coverage
| NTHINeOnc Technologies Holdings, Inc. | Sep 24, 2026 | BUY | Initiated | $20.00 | 1Ratings | -16.00% | ||
| MDCXMedicus Pharma Ltd | Sep 09, 2026 | BUY | Reiterated | $450.00 | 5Ratings | -78.98% | ||
| APVOAptevo Therapeutics | Sep 03, 2026 | BUY | Reiterated | $21.00 | 12Ratings | -71.75% | ||
| CELZCreative Medical Technology Holdings | Aug 20, 2026 | BUY | Reiterated | $20.00 | 9Ratings | -30.27% | ||
| GTBPGT Biopharma | Aug 17, 2026 | BUY | Reiterated | $3.00 | 6Ratings | -56.63% | ||
| CLNNClene | Aug 17, 2026 | BUY | Reiterated | $30.00 | 7Ratings | -31.17% | ||
| TENXTenax Therapeutics | Aug 10, 2026 | BUY | Reiterated | $5.00 | 8Ratings | +21.71% | ||
| REVBRevelation Biosciences | Aug 07, 2026 | BUY | Reiterated | $16.00 | 14Ratings | -82.31% | ||
| ZVRAZevra Therapeutics | Aug 06, 2026 | BUY | Reiterated | $21.00 | 18Ratings | +20.02% | ||
| MBRXMoleculin Biotech | Aug 04, 2026 | BUY | Reiterated | $620.00 | 17Ratings | -62.82% |
Disclaimer: TipRanks collects analysts’ ratings and price targets by scanning publicly available reports on financial websites and by receiving reports from analysts, firms, or customers. The information and statistics displayed might not be accurate, complete, or up-to-date. The analyst ratings provided are the sole responsibility of the source publication. TipRanks holds no liability over the analysts' information, price targets, ratings, or opinions expressed. See how TipRanks ranks experts and calculates performance.
Send Us Reports
If you receive reports that you think we are missing, we will thank you with a free Ultimate upgrade!
Learn More >Jonathan Aschoff activity FAQ
What is the performance of Jonathan Aschoff's recommendations?
The percentage of profitable recommendations made by Jonathan Aschoff is 27.20%, and the average return per transaction is -23.90%.
What stocks does Jonathan Aschoff cover?
Jonathan Aschoff mostly covers NeOnc Technologies Holdings, Inc., Medicus Pharma Ltd, Aptevo Therapeutics stocks.
What was Jonathan Aschoff's most profitable rating?
Jonathan Aschoff’s most profitable rating was a buy on Seelos Therapeutics stock on Sep 09, 2020. The return on the trade was 523.50%.
Where can I see a list of stock analyst ratings?
You can see a list of daily stock analyst ratings here.
What are the most recommended stocks by analysts?
You can see a list of the most recommended stocks by analysts here